Functional disruption of human leukocyte antigen II in human embryonic stem cell
BACKGROUND: Theoretically human embryonic stem cells (hESCs) have the capacity to self-renew and differentiate into all human cell types. Therefore, the greatest promise of hESCs-based therapy is to replace the damaged tissues of patients suffering from traumatic or degenerative diseases by the exact same type of cells derived from hESCs. Allo-graft immune rejection is one of the obstacles for hESCs-based clinical applications. Human leukocyte antigen (HLA) II leads to CD4+ T cells-mediated allograft rejection. Hence, we focus on optimizing hESCs for clinic application through gene modification RESULTS: Transcription activator-like effector nucleases (TALENs) were used to target MHC class II transactivator (CIITA) in hESCs efficiently. CIITA-/-hESCs did not show any difference in the differentiation potential and self-renewal capacity. Dendritic cells (DCs) derived from CIITA-/-hESCs expressed CD83 and CD86 but without the constitutive HLA II. Fibroblasts derived from CIITA-/-hESCs were powerless in IFN-γ inducible expression of HLA II CONCLUSION: We generated HLA II defected hESCs via deleting CIITA, a master regulator of constitutive and IFN-γ inducible expression of HLA II genes. CIITA-/-hESCs can differentiate into tissue cells with non-HLA II expression. It's promising that CIITA-/-hESCs-derived cells could be used in cell therapy (e.g., T cells and DCs) and escape the attack of receptors' CD4+ T cells, which are the main effector cells of cellular immunity in allograft
Main Authors: | Chen,Haide, Li,Yang, Lin,Xijuan, Cui,Di, Cui,Chun, Li,Hui, Xiao,Lei |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedad de Biología de Chile
2015
|
Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602015000100059 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
bFGF promotes adipocyte differentiation in human mesenchymal stem cells derived from embryonic stem cells
by: Song,Xinghui, et al.
Published: (2014) -
Therapeutic use of human embryonic stem cells
by: Aznar,Justo, et al.
Published: (2014) -
A future without human leukocyte antigens?
by: Gilli,Simone Cristina Olenscki
Published: (2018) -
The Use of embryonic stem cells in therapeutic research: report of the IBC on the ethical aspects of human embryonic stem cell research
by: Meeting of the Extended Working Group on the Ethical Aspects of Embryonic Stem Cell Research, Paris, 2001, et al. -
Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation
by: Cardozo,Daniela Máira, et al.
Published: (2012)